SE0301922D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- SE0301922D0 SE0301922D0 SE0301922A SE0301922A SE0301922D0 SE 0301922 D0 SE0301922 D0 SE 0301922D0 SE 0301922 A SE0301922 A SE 0301922A SE 0301922 A SE0301922 A SE 0301922A SE 0301922 D0 SE0301922 D0 SE 0301922D0
- Authority
- SE
- Sweden
- Prior art keywords
- alkyl
- ring
- aryl
- heteroaryl
- heterocycloalkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
- C07D295/26—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Heart & Thoracic Surgery (AREA)
- Dermatology (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301922A SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Novel compounds |
NZ544208A NZ544208A (en) | 2003-06-27 | 2004-06-23 | N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyformamide compounds as metalloproteinase inhibitors |
CN201110103041XA CN102229589A (zh) | 2003-06-27 | 2004-06-23 | 作为金属蛋白酶抑制剂的n-{4′-取代的哌嗪-1-磺酰基甲基烷基}-n-羟基甲酰胺化合物 |
CN2004800182447A CN1812974B (zh) | 2003-06-27 | 2004-06-23 | 作为金属蛋白酶抑制剂的n-{‘4-取代的哌嗪-1-磺酰基甲基烷基}-n-羟基甲酰胺化合物 |
US10/561,747 US7485644B2 (en) | 2003-06-27 | 2004-06-23 | N-{'4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
CA002529468A CA2529468A1 (en) | 2003-06-27 | 2004-06-23 | N-{[4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
UAA200511723A UA81491C2 (en) | 2003-06-27 | 2004-06-23 | N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors, pharmaceutical composition based thereon, proces for the preparation thereof, intermediate (variants) |
JP2006516467A JP4701167B2 (ja) | 2003-06-27 | 2004-06-23 | メタロプロテイナーゼ阻害剤としてのn−{(4−置換ピペラジン−1−スルホニルメチル)アルキル}−n−ヒドロキシホルムアミド化合物 |
PCT/GB2004/002702 WO2005000822A1 (en) | 2003-06-27 | 2004-06-23 | N-{‘4-substituted piperazine-1-sulfonylmethyl!alkyl}-n-hydroxyfomamide compounds as metalloproteinase inhibitors |
PL04743053T PL1644340T3 (pl) | 2003-06-27 | 2004-06-23 | N-[({4-podstawione związki piperazyn-1-ylo}sulfonylometylo)alkilo]-n-hydroksyformamidowe jako inhibitory metaloproteinazy |
RU2005141058/04A RU2351595C2 (ru) | 2003-06-27 | 2004-06-23 | N-гидроксиформамидные соединения в качестве ингибиторов металлопротеиназ |
SI200430979T SI1644340T1 (sl) | 2003-06-27 | 2004-06-23 | N-(((4'-substituiran-piperazin-1-il)sulfonilmetil)alkil)-N- hidrioksiformamidne spojine kot metaloproteinazni inhibitorji |
KR1020057024709A KR20060026440A (ko) | 2003-06-27 | 2004-06-23 | 메탈로프로테이나제 억제제로서의 n-[4-치환된피페라진-1-술포닐메틸알킬]-n-히드록시포름아미드 화합물 |
ES04743053T ES2315675T3 (es) | 2003-06-27 | 2004-06-23 | Compuestos de n-(((4-sustituida piperazin-1-il)sulfonil-metil)alquil)-n-hidroxiformamida como inhibidores de metaloproteinasa. |
AU2004251104A AU2004251104B2 (en) | 2003-06-27 | 2004-06-23 | N-{'4-substituted piperazine-1-sulfonylmethyl!alkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors |
PT04743053T PT1644340E (pt) | 2003-06-27 | 2004-06-23 | Compostos de n-[({4¿-piperazina substituída-1-sulfonilmetil)alquil}]-n-hidroxiformamida como inibidores de metaloproteinases |
DE602004017733T DE602004017733D1 (de) | 2003-06-27 | 2004-06-23 | N-Ä(ä4-SUBSTITUIERTEN PIPERAZIN-1-YLüSULFONYLMETHYL) ALKYLÜ -N-HYDROXYFORMAMIDE VERBINDUNGEN ALS METALLOPROTEINASE INHIBITOREN |
BRPI0411929-0A BRPI0411929A (pt) | 2003-06-27 | 2004-06-23 | compostos de piperazino-(1-sulfonilmetil-alquil)n-hidróxiformami da n-(4 ' -substituìdos) como inibidores de metaloproteinase |
MXPA05013460A MXPA05013460A (es) | 2003-06-27 | 2004-06-23 | Compuestos de n-{piperazina '4-sustituida-1-sulfonilmetil-alquil}-n-hidroxiformamida como inhibidores de metaloproteinasas. |
DK04743053T DK1644340T3 (da) | 2003-06-27 | 2004-06-23 | N-[ ( { ' 4-substitueret piperazin-1-yl } sulfonylmethyl ) alkyl ] -N-hydroxyformamidforbindelser som metalloproteinaseinhibitorer |
EP04743053A EP1644340B1 (en) | 2003-06-27 | 2004-06-23 | N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors |
AT04743053T ATE414063T1 (de) | 2003-06-27 | 2004-06-23 | N-ä(ä4-substituierten piperazin-1- ylüsulfonylmethyl) alkylü -n-hydroxyformamide verbindungen als metalloproteinase inhibitoren |
TW093118692A TW200524898A (en) | 2003-06-27 | 2004-06-25 | Novel compounds |
UY28387A UY28387A1 (es) | 2003-06-27 | 2004-06-25 | Compuestos novedosos |
ARP040102258A AR044931A1 (es) | 2003-06-27 | 2004-06-25 | Compuestos de n-{'4-piperazina sustituida -1-sulfonilmetilalquil}-n-hidroxiformamidas como inhibidores de metaloproteasas |
MYPI20042517A MY138680A (en) | 2003-06-27 | 2004-06-25 | N-{4-substituted piperazine-1-sulfonylmethylalkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
SA04250224A SA04250224B1 (ar) | 2003-06-27 | 2004-07-14 | مركبات من n -[(4`-بيبرازين مستبدل -1-يل}سيلفونيل ميثيل) الكيل]-n-هيدروكسي فورمايد باعتبارها مثبطات انزيمات البروتين المعدني |
IL172615A IL172615A0 (en) | 2003-06-27 | 2005-12-15 | N-{4'-substituted piperazine -1-sulfonylmethyl-alkyl}-n- hydroxyformamide compounds as metalloproteinase inhibitors |
ZA200510458A ZA200510458B (en) | 2003-06-27 | 2005-12-22 | N-{4-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds are metalloproteinase inhibitors |
CO05130352A CO5650254A2 (es) | 2003-06-27 | 2005-12-27 | Compuestos n-[4-sustituido piperazin-1-sulfonilmetil-alquil]-n-hidroxiformamida como inhibidores de metaloproteinasa |
IS8257A IS8257A (is) | 2003-06-27 | 2006-01-23 | N-{[4-útskipt píperasín-1-súlfónýlmetýl]alkýl}-N-hýdroxýfómamíðefnasambönd sem málmprótínkljúfstálmar |
NO20060444A NO20060444L (no) | 2003-06-27 | 2006-01-27 | N-{4'-substituerte piperazin-1-sulfonylmetylalkyl}-N-hydroksyformamid forbindelser som metallproteinaseinhibitorer |
HK06106939A HK1086835A1 (en) | 2003-06-27 | 2006-06-17 | N-[({'4-substituted piperazine-1-y}sulfonylmethyl)alkyl]-n-hxdroxyformamide compounds as metallopro teinase inhibitors |
HR20090009T HRP20090009T3 (en) | 2003-06-27 | 2009-01-08 | N-{'4-substituted piperazine-1-sulfonylmethyl]alkyl}-n-hydroxyformamide compounds as metalloproteinase inhibitors |
CY20091100064T CY1108757T1 (el) | 2003-06-27 | 2009-01-19 | Ενωσεις ν-{'4-υποκατεστημενη πιπεραζινη-1-σουλφονυλμεθυλαλκυλ}-ν-υδροξυφορμαμιδιου ως αναστολεις της μεταλλοπρωτεϊνασης. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0301922A SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Novel compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0301922D0 true SE0301922D0 (sv) | 2003-06-27 |
Family
ID=27656653
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0301922A SE0301922D0 (sv) | 2003-06-27 | 2003-06-27 | Novel compounds |
Country Status (34)
Country | Link |
---|---|
US (1) | US7485644B2 (ru) |
EP (1) | EP1644340B1 (ru) |
JP (1) | JP4701167B2 (ru) |
KR (1) | KR20060026440A (ru) |
CN (2) | CN1812974B (ru) |
AR (1) | AR044931A1 (ru) |
AT (1) | ATE414063T1 (ru) |
AU (1) | AU2004251104B2 (ru) |
BR (1) | BRPI0411929A (ru) |
CA (1) | CA2529468A1 (ru) |
CO (1) | CO5650254A2 (ru) |
CY (1) | CY1108757T1 (ru) |
DE (1) | DE602004017733D1 (ru) |
DK (1) | DK1644340T3 (ru) |
ES (1) | ES2315675T3 (ru) |
HK (1) | HK1086835A1 (ru) |
HR (1) | HRP20090009T3 (ru) |
IL (1) | IL172615A0 (ru) |
IS (1) | IS8257A (ru) |
MX (1) | MXPA05013460A (ru) |
MY (1) | MY138680A (ru) |
NO (1) | NO20060444L (ru) |
NZ (1) | NZ544208A (ru) |
PL (1) | PL1644340T3 (ru) |
PT (1) | PT1644340E (ru) |
RU (1) | RU2351595C2 (ru) |
SA (1) | SA04250224B1 (ru) |
SE (1) | SE0301922D0 (ru) |
SI (1) | SI1644340T1 (ru) |
TW (1) | TW200524898A (ru) |
UA (1) | UA81491C2 (ru) |
UY (1) | UY28387A1 (ru) |
WO (1) | WO2005000822A1 (ru) |
ZA (1) | ZA200510458B (ru) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0427403D0 (en) | 2004-12-15 | 2005-01-19 | Astrazeneca Ab | Novel compounds I |
JP5203956B2 (ja) * | 2005-10-26 | 2013-06-05 | メルク セローノ ソシエテ アノニム | メタロプロテイナーゼの調節のためのスルホンアミド誘導体とその使用 |
CN101007794B (zh) * | 2006-01-26 | 2010-09-01 | 中国科学院上海药物研究所 | N,n'-二取代哌嗪类衍生物及其制备方法、药物组合物和用途 |
WO2009151910A2 (en) * | 2008-05-25 | 2009-12-17 | Wyeth | Combination product of receptor tyrosine kinase inhibitor and fatty acid synthase inhibitor for treating cancer |
ES2592154T3 (es) * | 2010-07-08 | 2016-11-28 | Kaken Pharmaceutical Co., Ltd. | Derivado de N-hidroxiformamida y medicamento que contiene el mismo |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL200418B1 (pl) * | 1998-01-30 | 2009-01-30 | Darwin Discovery Ltd | Pochodna N-hydroksyformamidu, zawierający ją środek farmaceutyczny i jej zastosowanie |
GB9919776D0 (en) * | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
NZ515829A (en) * | 1999-06-04 | 2003-10-31 | Astrazeneca Ab | Inhibitors of metalloproteinases |
HUP0302723A3 (en) | 2000-02-21 | 2007-09-28 | Astrazeneca Ab | Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases, process for their preparation and pharmaceutical compositions containing them |
GB0119472D0 (en) * | 2001-08-09 | 2001-10-03 | Astrazeneca Ab | Compounds |
US7119203B2 (en) * | 2002-04-25 | 2006-10-10 | Pharmacia Corporation | Piperidinyl- and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
EP1641771B1 (en) * | 2003-06-19 | 2008-10-15 | UCB Pharma, S.A. | Hydroxamate sulfonamides as cd23 shedding inhibitors |
-
2003
- 2003-06-27 SE SE0301922A patent/SE0301922D0/xx unknown
-
2004
- 2004-06-23 BR BRPI0411929-0A patent/BRPI0411929A/pt not_active IP Right Cessation
- 2004-06-23 EP EP04743053A patent/EP1644340B1/en not_active Expired - Lifetime
- 2004-06-23 PL PL04743053T patent/PL1644340T3/pl unknown
- 2004-06-23 WO PCT/GB2004/002702 patent/WO2005000822A1/en active Application Filing
- 2004-06-23 DK DK04743053T patent/DK1644340T3/da active
- 2004-06-23 US US10/561,747 patent/US7485644B2/en not_active Expired - Fee Related
- 2004-06-23 DE DE602004017733T patent/DE602004017733D1/de not_active Expired - Lifetime
- 2004-06-23 CA CA002529468A patent/CA2529468A1/en not_active Abandoned
- 2004-06-23 JP JP2006516467A patent/JP4701167B2/ja not_active Expired - Fee Related
- 2004-06-23 PT PT04743053T patent/PT1644340E/pt unknown
- 2004-06-23 MX MXPA05013460A patent/MXPA05013460A/es active IP Right Grant
- 2004-06-23 AU AU2004251104A patent/AU2004251104B2/en not_active Ceased
- 2004-06-23 SI SI200430979T patent/SI1644340T1/sl unknown
- 2004-06-23 NZ NZ544208A patent/NZ544208A/en unknown
- 2004-06-23 RU RU2005141058/04A patent/RU2351595C2/ru not_active IP Right Cessation
- 2004-06-23 UA UAA200511723A patent/UA81491C2/uk unknown
- 2004-06-23 CN CN2004800182447A patent/CN1812974B/zh not_active Expired - Fee Related
- 2004-06-23 ES ES04743053T patent/ES2315675T3/es not_active Expired - Lifetime
- 2004-06-23 CN CN201110103041XA patent/CN102229589A/zh active Pending
- 2004-06-23 AT AT04743053T patent/ATE414063T1/de active
- 2004-06-23 KR KR1020057024709A patent/KR20060026440A/ko active IP Right Grant
- 2004-06-25 MY MYPI20042517A patent/MY138680A/en unknown
- 2004-06-25 TW TW093118692A patent/TW200524898A/zh unknown
- 2004-06-25 UY UY28387A patent/UY28387A1/es unknown
- 2004-06-25 AR ARP040102258A patent/AR044931A1/es not_active Application Discontinuation
- 2004-07-14 SA SA04250224A patent/SA04250224B1/ar unknown
-
2005
- 2005-12-15 IL IL172615A patent/IL172615A0/en unknown
- 2005-12-22 ZA ZA200510458A patent/ZA200510458B/xx unknown
- 2005-12-27 CO CO05130352A patent/CO5650254A2/es not_active Application Discontinuation
-
2006
- 2006-01-23 IS IS8257A patent/IS8257A/is unknown
- 2006-01-27 NO NO20060444A patent/NO20060444L/no not_active Application Discontinuation
- 2006-06-17 HK HK06106939A patent/HK1086835A1/xx not_active IP Right Cessation
-
2009
- 2009-01-08 HR HR20090009T patent/HRP20090009T3/xx unknown
- 2009-01-19 CY CY20091100064T patent/CY1108757T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2500680C2 (ru) | Новые замещенные пиридин-2-оны и пиридазин-3-оны | |
RU2336275C2 (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью, и фармацевтическая композиция | |
RU2397168C2 (ru) | Производные тиофена в качестве ингибиторов снк 1 | |
RU2403258C2 (ru) | Тиазолилдигидроиндазолы | |
AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
ME00411B (me) | Nova jedinjenja koja imaju inhibitorno dejstvo na transporter glukoze zavistan od natrijuma | |
NO20055568L (no) | Substituerte 1,4-diazepiner og anvendelser derav | |
EA200301216A1 (ru) | Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания | |
MXPA04001016A (es) | Derivados de sulfonamida como inhibidores de la gamma secretasa. | |
PE20040164A1 (es) | Mimeticos de glucocorticoides, procedimientos para su preparacion y composiciones farmaceuticas | |
EA200601235A1 (ru) | Производные тиазола | |
PE20090042A1 (es) | Analogos de ciclopamina | |
MXPA05007496A (es) | Tienopirimidindionas y su uso en la modulacion de enfermedades autoinmunes. | |
EA200701035A1 (ru) | Замещенные n-сульфониламинобензил-2-феноксиацетамидные соединения | |
EA200500006A1 (ru) | Лекарственное средство для лечения нейродегенеративных заболеваний | |
NO20001402L (no) | Substituerte kromanderivater | |
PE20230182A1 (es) | Uso y composicion farmaceutica de derivados de fenilisoxazolil metilen-naftaleno-eter | |
EA200500717A1 (ru) | Новые соединения имидазопиридина, способ их получения и фармацевтические композиции, которые их содержат | |
CY1108757T1 (el) | Ενωσεις ν-{'4-υποκατεστημενη πιπεραζινη-1-σουλφονυλμεθυλαλκυλ}-ν-υδροξυφορμαμιδιου ως αναστολεις της μεταλλοπρωτεϊνασης. | |
ATE276257T1 (de) | Pyrazinonderivate | |
ATE525366T1 (de) | Benzoxazolderivate und pharmazeutische zubereitungen die diese enthalten | |
EA200400806A1 (ru) | Способ получения эхинокандиновых соединений | |
ATE442354T1 (de) | Pyrrolidinderivate als oxytocin antagonisten | |
EA200600551A1 (ru) | Соединения пиперазина, способ их получения и фармацевтические композиции, которые их содержат | |
PE20071083A1 (es) | Derivados nuevos indolizina, su proceso de preparacion y las composiciones terapeuticas que las contienen |